IBM Seeks Shareholder Approval for New Long-Term Performance Plan with 10.16% Potential Dilution
Summary
IBM filed its definitive proxy statement for the upcoming Annual Meeting, seeking shareholder approval for a new Long-Term Performance Plan that could result in 10.16% potential dilution, alongside routine governance matters and executive compensation votes.
Key Events
-
Annual Meeting Scheduled
IBM will hold its Annual Meeting of Stockholders virtually on Tuesday, April 28, 2026, to vote on several key proposals.
-
New Long-Term Performance Plan Proposed
The Board seeks approval for the 2026 Long-Term Performance Plan (LTPP), which would authorize 80 million shares for equity awards, representing a potential fully diluted overhang of approximately 10.16% of outstanding shares. This plan replaces several prior LTPP plans.
-
Strong Governance Features in LTPP
The proposed LTPP includes provisions prohibiting repricing of underwater options, granting discounted stock options, and automatic vesting upon change of control. It also mandates a 12-month holding period for the CEO's net shares acquired from equity awards.
-
Executive Compensation Details
Shareholders will cast an advisory vote on executive compensation. CEO Arvind Krishna's 2025 total compensation was $37.99 million, with 95% of his target pay being performance-based. A relative Total Shareholder Return (rTSR) modifier was introduced to the long-term incentive plan in 2025.
Analysis
IBM has filed its definitive proxy statement, outlining proposals for its upcoming Annual Meeting. The most significant item is the request for shareholder approval of a new 2026 Long-Term Performance Plan (LTPP). This plan would authorize a total of 80 million shares for equity awards, representing a potential fully diluted overhang of approximately 10.16% of outstanding shares. While this level of potential dilution is substantial, the plan incorporates strong governance features such as prohibitions against repricing underwater options, granting discounted stock options, and automatic vesting upon change of control, along with a 12-month holding period for the CEO. These features aim to align executive incentives with long-term shareholder value. The proxy also details executive compensation, with CEO Arvind Krishna's 2025 total compensation at $37.99 million, largely performance-based, and introduces a relative Total Shareholder Return (rTSR) modifier to the long-term incentive plan. Additionally, the company proposes the election of directors, including new appointee Ramon Laguarta, and seeks ratification of its independent auditor. Several routine stockholder proposals, which the Board recommends against, are also included. The overall sentiment is neutral to slightly negative, as the dilution is a material event, but it is balanced by robust governance practices and the company's strong recent financial performance, indicating the plan is for growth and talent retention rather than distress.
At the time of this filing, IBM was trading at $250.65 on NYSE in the Technology sector, with a market capitalization of approximately $234.7B. The 52-week trading range was $214.50 to $324.90. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.